Accessibilità e comodità di lettura

Dimensione del testo

Modalità chiaro/scuro

Spaziatura verticale delle linee

Problemi con l'utilizzo del nostro sito web?
Contattaci

Il dottor Philipp Herrmann

In questa pagina

Informazioni sui membri

Dr Philipp Herrmann

Sostituire

Germania

Gruppi di lavoro: Malattie rare dell'occhio della retina (WG1), Diagnostica genetica (TWG6), Ricerca (TWG8), CPMS e medicina digitale (TWG10)

Squadra

Centro HCP

Il reparto per le malattie degli occhi copre l'intera gamma degli interventi chirurgici oftalmologici e offre assistenza per tutti gli esami e...

contatti

University of Bonn, Germany

Ernst-Abbe-Strasse 2
53127 Bonn
Germany

Test clinici

NCT05698316 Reclutamento, attivo

A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression: (INTERCEPT-AMD)

osservazionale
Vedi il processo
vedere la scheda

NCT01835002 Completato

This is a single-arm open label interventional safety trial with RP patients, who receive weekly TES for 6 months on 1 eye followed by observation for another 6 months without stimulation. The primary outcome measure is safety, indicated by the frequency and severity of adverse events.

interventistica
Vedi il processo
vedere la scheda
2018-001496-20 Reclutamento, attivo

Clinical trials for A multi-national, multi-centre, double-masked, placebo-controlled proof of concept trial to evaluate the safety and efficacy of oral Soraprazan in Stargardt Phase 2, disease SMR-3438, Katairo

interventistica
Vedi il processo
vedere la scheda
NCT03584165 Reclutamento, attivo

A Long-term Follow-up Study to Evaluate the Safety and efficacy of Retinal Gene Therapy in Subjects with choroideremia treated previously with Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1) in an Antecedent Study.

interventistica
Vedi il processo
vedere la scheda
NCT02410122 Completato

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy (ProgStar-4).

osservazionale
Vedi il processo
vedere la scheda
NCT05811351 Reclutamento, attivo

A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

interventistica
Vedi il processo
vedere la scheda
NCT03364153 Attivo, non reclutante

A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease

interventistica
Vedi il processo
vedere la scheda
NCT04435366 Completato

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

interventistica
Vedi il processo
vedere la scheda
NCT05384249 Reclutamento, attivo

A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Non-infectious, Intermediate-, Posterior- or Pan-uveitis

interventistica
Vedi il processo
vedere la scheda
NCT03525600 Completato

A Phase 3, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal Pegcetacoplan Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

interventistica
Vedi il processo
vedere la scheda
NCT04770545 Attivo, non reclutante

A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

interventistica
Vedi il processo
vedere la scheda
DRKS00023562 Reclutamento, attivo

Evaluation of the effectiveness of transcorneal electrostimulation in patients with retinitis pigmentosa - a multicenter, prospective, randomized, controlled and double-blind study on behalf of the G-BA

interventistica
Vedi il processo
vedere la scheda

Pubblicazioni scientifiche

Repeatability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients With Recessive Stargardt Disease 1